Erosive pustular dermatosis-like eruption of the scalp secondary to amivantamab: A case series
Authors:
- Mariya N. GeorgeMGMariya N. George
- Riyad N.H. SeervaiRSRiyad N.H. Seervai
- Susan Y. ChonSCSusan Y. Chon
Open Access
- 17 January 2024
- journal article
- Published by Elsevier in JAAD Case Reports
- Vol. 47, 72-79
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- RETRACTED ARTICLE: Tarsoconjunctival Granulation Tissue Formation Associated with EGFR InhibitorsOncology and Therapy, 2022
- BH15: Erosive pustular dermatosis of the scalp in a patient commenced on a bispecific antibody targeting epidermal growth factor receptor and mesenchymal–epithelial transition factorBritish Journal of Dermatology, 2022
- Erosive pustular dermatosis of the scalp‐like eruption from panitumumabAustralasian Journal of Dermatology, 2022
- Diverse landscape of dermatologic toxicities from small‐molecule inhibitor cancer therapyJournal of Cutaneous Pathology, 2021
- Afatinib-induced erosive pustular dermatosis of the scalp: Is there a synergistic effect between EGFR inhibitors and radiotherapy?Dermatologic Therapy, 2020
- Erosive pustular dermatosis of the scalp: causes and treatmentsInternational Journal of Dermatology, 2020
- Erosive pustular dermatosis of the scalp: a multicentre studyJournal of the European Academy of Dermatology and Venereology, 2020
- Erosive Pustular Dermatosis of the Scalp-Like Eruption due to Gefitinib: Case Report and Review of the Literature of Alopecia Associated with EGFR InhibitorsDermatology, 2012
- Erosive pustular dermatosis of the scalp: A review with a focus on dapsone therapyJournal of the American Academy of Dermatology, 2012
- Cutaneous side effects of epidermal growth factor receptor inhibitors: Clinical presentation, pathogenesis, and managementJournal of the American Academy of Dermatology, 2007